CARLSBAD, Calif., Sept. 21, 2023 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that TYRA will deliver oral presentations on TYRA-300 for achondroplasia at the American Society for Bone and Mineral Research (ASBMR) and the American Society of Human Genetics (ASHG) 2023 annual meetings. ASBMR is taking place October 13-16, 2023, in Vancouver, BC, Canada and ASHG is taking place November 1-5, 2023, in Washington, DC.
ASBMR presentation details:
Presentation Number: 1077
Session: Oral Presentations: Skeletal Development and Disease
Presentation Date/Time: Sunday, October 15, 2023, 10:00 AM
TYRA Presenter: Ronald Swanson, Ph.D., Chief Scientific Officer
ASHG presentation details:
Session: Oral Presentations: Precision prescription: The therapeutic potential of ASOs and small molecules for genetic disorders Presentation Date/Time: Friday, November 3, 2023, 12:00 PM
TYRA Presenter: Jacqueline H. Starrett, PhD, Associate Director, In Vivo Pharmacology
More information on the annual meetings can be found below:
ASBMR 2023 Annual Meeting - American Society for Bone and Mineral Research
ASHG 2023 Scientific Program and Schedule of Events - ASHG
The presentation materials will be made available via the For Investors page on the Investor section of the TYRA website.
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in Carlsbad, CA. For more information about our science, pipeline and people, please visit
www.tyra.bio and engage with us on